Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Vera Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 84 | 1 | 95 | +12 |
| Shares | 39.3M | 758.4K | 41.4M | +2.93M (+7.6%) |
| Value | $538.2M | $10.4M | $637.2M | +$109.4M (+20.7%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Vera Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (10)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Polar Asset Management Partners Inc. | 135,755 | $1.86M |
| Sphera Funds Management Ltd. | 105,000 | $1.44M |
| Renaissance Technologies LLC | 87,200 | $1.20M |
| Wellington Management Group LLP | 84,506 | $1.16M |
| Jane Street Group, LLC | 83,025 | $1.14M |
| Tri Locum Partners LP | 43,438 | $595.5K |
| XTX Topco Ltd | 32,048 | $439.4K |
| HighVista Strategies LLC | 30,902 | $423.7K |
| Ensign Peak Advisors, Inc | 17,816 | $244.3K |
| Mariner, LLC | 11,038 | $151.3K |
Not filed for Q4 2023 yet (1)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 758,355 | $10.4M |